Literature DB >> 13711446

Relation between Gm types and hemagglutinating substances in rheumatoid sera.

M HARBOE.   

Abstract

Entities:  

Keywords:  ANTIBODIES; ARTHRITIS, RHEUMATOID/immunology

Mesh：

Substances：

Year:  1960        PMID： 13711446     DOI： 10.1111/j.1699-0463.1960.tb01175.x

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Scand        ISSN： 0365-5555


× No keyword cloud information.
  6 in total

1.  [ANOTHER SERUM GROUP].

Authors:  H KLEIN; I KLOSE
Journal:  Klin Wochenschr       Date:  1963-10-01

2.  Determination of human immunoglobulin M rheumatoid factor by a solid-phase radioimmunoassay which uses human immunoglobulin G in antigen-antibody complexes.

Authors:  B Ziola; O Meurman; M T Matikainen; A Salmi; J L Kalliomäki
Journal:  J Clin Microbiol       Date:  1978-08       Impact factor: 5.948

3.  Heteroclitic polyclonal and monoclonal anti-Gm(a) and anti-Gm(g) human rheumatoid factors react with epitopes induced in Gm(a-), Gm(g-) IgG by interaction with antigen or by nonspecific aggregation. A possible mechanism for the in vivo generation of rheumatoid factors.

Authors:  R C Williams; C C Malone; P Casali
Journal:  J Immunol       Date:  1992-09-01       Impact factor: 5.422

4.  Reaction of rheumatoid factors with IgG3 monoclonal anti-Rh(D) antibodies: more frequent reactivity to a monoclonal antibody of the Gm allotype G3m(5) in rheumatoid patients negative for G3m(5).

Authors:  A H Puttick; E A Williamson; A H Merry; B M Kumpel; K M Thompson; V E Jones
Journal:  Ann Rheum Dis       Date:  1988-11       Impact factor: 19.103

5.  A new assay uses monoclonal anti-Rh(D) antibodies to determine rheumatoid factor specificity: reactivity to a monoclonal antibody of the Gm allotype G3m(21) is more frequent in rheumatoid patients negative for G3m(21)

Authors:  V E Jones; A H Puttick; E A Williamson; R A Mageed
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

6.  Specificity of the reaction between rheumatoid factors and gamma globulin.

Authors:  H H FUDENBERG; H G KUNKEL
Journal:  J Exp Med       Date:  1961-08-01       Impact factor: 14.307
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.